$289 Million is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $42,556,000 | +17.7% | 862,848 | +0.5% | 14.73% | +39.5% |
| UTHR | Sell | UNITED THERAPEUTICS CORP | $41,721,000 | -14.8% | 249,421 | -22.7% | 14.44% | +1.0% |
| TARO | Sell | TARO PHARMACEUTICAL INDUS | $40,388,000 | -0.6% | 547,639 | -1.1% | 13.98% | +17.8% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $39,128,000 | -1.5% | 82,698 | +0.6% | 13.54% | +16.8% |
| BIIB | Buy | BIOGEN INC | $38,750,000 | +14.7% | 138,518 | +0.4% | 13.41% | +35.9% |
| MCK | Buy | MCKESSON CORP | $32,697,000 | +12.6% | 167,640 | +0.4% | 11.32% | +33.5% |
| ALKS | Buy | ALKERMES PLC | $30,398,000 | -6.0% | 1,627,323 | +0.4% | 10.52% | +11.4% |
| SRGA | Buy | SURGALIGN HOLDINGS INC | $14,060,000 | -0.0% | 6,449,408 | +0.4% | 4.87% | +18.5% |
| IVC | Buy | INVACARE CORP | $7,284,000 | -10.0% | 908,236 | +0.4% | 2.52% | +6.6% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $1,057,000 | -98.1% | 6,912 | -98.1% | 0.37% | -97.8% |
| ANAB | Sell | ANAPTYSBIO INC | $554,000 | -76.7% | 25,690 | -76.7% | 0.19% | -72.3% |
| NXTC | Buy | NEXTCURE INC | $306,000 | -7.3% | 30,603 | +1.0% | 0.11% | +10.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-18
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 36 | Q3 2023 | 18.1% |
| Enanta Pharmceuticals Inc | 35 | Q3 2023 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| BIOGEN INC | 19 | Q3 2023 | 16.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
| DIGIRAD CORP | 18 | Q1 2019 | 1.0% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 16.1% |
| ALKERMES PLC | 16 | Q3 2023 | 14.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-17 |
| 13F-HR | 2022-02-15 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.